| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Cholesterol biosynthesis with skeletal dysplasias 0.8619914026093974 2.388711888804642 0.016907555559275 0.9999680275796168 0.8298258624013215 6 Q14739,Q15392 2 |
| Metapathway biotransformation phase i and ii 0.5773714510027289 2.208158004602377 0.0272332607154281 0.999999947363295 0.8298258624013215 25 O15217,P07099,Q86UY6,Q7LGA3 4 |
| Sphingolipid metabolism integrated pathway 0.8032748913846623 2.1776982142495687 0.029428511955877 0.9999999866429612 0.8298258624013215 7 P27544,Q06136,Q96G23 3 |
| Sphingolipid metabolism overview 0.8032748913846623 2.1776982142495687 0.029428511955877 0.9999999866429612 0.8298258624013215 7 P27544,Q06136,Q96G23 3 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.9023671085560924 2.1337226731053813 0.03286548895933 0.9999999984492682 0.8298258624013215 4 P07099 1 |
| Male infertility 0.5741890168215849 2.077699693297898 0.0377370273245269 0.9999999999276696 0.8298258624013215 24 Q9UFC0,Q8IWV8,P08183,Q15165 4 |
| Allograft rejection 0.7453654898228035 2.0445010088074813 0.0409040778475771 0.9999999999902216 0.8298258624013215 10 P08670,P42574,P01889,P42224,P08183 5 |
| Omega3 omega6 fatty acid synthesis 0.7790350967111059 2.0338338736197827 0.0419683479678258 0.999999999995016 0.8298258624013215 6 O15254,Q15067 2 |
| Metabolism of spingolipids in er and golgi apparatus 0.940598335131557 1.9892145170910565 0.0466775302253874 0.9999999999997496 0.8298258624013215 3 Q06136 1 |
| Nonalcoholic fatty liver disease 0.4484504550376958 1.9890072890997048 0.0467003984220872 0.9999999999997532 0.8298258624013215 55 P21912,Q96J02,P42574,P51970,O14949,P00403,Q86Y39,O43676,P14406,Q9P0J0,P54646,P22695,P14854,P47985 14 |
| Nanomaterial induced apoptosis 0.7591098242444093 1.9824137108009396 0.0474329563008097 0.9999999999998452 0.8298258624013215 7 O95831,Q9NR28 2 |
| Statin inhibition of cholesterol production 0.8315469483279385 1.9713136023876912 0.0486880164426692 0.9999999999999304 0.8298258624013215 5 Q8WTV0,P35610,P37268 3 |
| Ketogenesis and ketolysis 0.7498411286730372 1.9409132547830572 0.0522687999955477 0.999999999999993 0.8298258624013215 7 P23786,O43772,P53985,P11166 4 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5350368855863247 1.9124961223713004 0.0558125895059522 0.9999999999999992 0.8298258624013215 25 P35610,O95864,P48449,Q16850,Q14739,Q15392,O76062,P37268 8 |
| 1q211 copy number variation syndrome 0.720634321530427 1.8846990766890128 0.0594704771019378 1.0 0.8298258624013215 9 Q9NPH0,P54646 2 |
| Apoptosis modulation by hsp70 0.7983788017157514 1.835596183885718 0.0664174019782943 1.0 0.8298258624013215 5 O95831 1 |
| Mitochondrial complex iv assembly 0.6806809632257311 1.8248863244365745 0.0680181853459145 1.0 0.8298258624013215 12 P14854,P00403,P14406 3 |
| Proteoglycan biosynthesis 0.8888174055283873 1.7899963429596488 0.0734544993059813 1.0 0.8298258624013215 3 Q8TB61 1 |
| Mitochondrial complex i assembly model oxphos system 0.4991751433883843 1.7685050213089215 0.0769765134981161 1.0 0.8298258624013215 27 P51970,Q96CU9,P03886,O43676,Q9P0J0 5 |
| Heme biosynthesis 0.778953342826067 1.7553232005953354 0.0792040402210361 1.0 0.8298258624013215 5 P22830,P06132 2 |
| Oxidation by cytochrome p450 0.7110138951462841 1.7325427290011317 0.0831769761556189 1.0 0.8298258624013215 6 O43169 1 |
| Type ii interferon signaling ifng 0.7037524862289675 1.7320206391273616 0.0832698877551703 1.0 0.8298258624013215 7 Q03518,P42224 2 |
| Eicosanoid synthesis 0.8695652173913055 1.7151892745680095 0.0863105306465734 1.0 0.8298258624013215 3 P09960,Q9H7Z7 2 |
| Reninangiotensinaldosterone system raas 0.7919700397119225 1.6933830729228854 0.0903825747453359 1.0 0.8298258624013215 4 Q13555,Q13557 2 |
| Ethanol effects on histone modifications 0.6495369233850582 1.667475208992266 0.0954199499472712 1.0 0.8298258624013215 12 Q9H9T3,O94788,P04818,O14929,P00374 5 |
| Influence of laminopathies on wnt signaling 0.6594549907398913 1.5940309398422166 0.1109291052455705 1.0 0.8298258624013215 9 P48729,P50402,O75844,O60725,P49354 5 |
| Sphingolipid pathway 0.6629488691341177 1.575851935736836 0.1150599300366135 1.0 0.8298258624013215 8 O95470,Q06136,Q96G23 3 |
| Electron transport chain oxphos system in mitochondria 0.4172387319346053 1.5710529494970666 0.1161703501946402 1.0 0.8298258624013215 52 P21912,P51970,P00403,P03886,P14854,O43676,P14406,P22695,O75964 9 |
| Disruption of postsynaptic signaling by cnv 0.6510126796982326 1.5533726716917615 0.120334127824496 1.0 0.8298258624013215 9 Q14168,Q7L576,Q13555 3 |
| Tryptophan metabolism 0.5979057287972898 1.541610001025384 0.1231683937873411 1.0 0.8298258624013215 15 Q15392,P51648,Q16836,O94788 4 |
| 15q112 copy number variation syndrome 0.7520808455764769 1.5304056473560677 0.1259163519862296 1.0 0.8298258624013215 4 Q7L576,Q96CW5 2 |
| Immune response to tuberculosis 0.822158012352962 1.5296186201334745 0.1261111577454219 1.0 0.8298258624013215 3 Q03518 1 |
| Wnt signaling 0.5752763579631209 1.525699966279238 0.1270846029263797 1.0 0.8298258624013215 17 P61586,Q13555,P48729 3 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.6570160752336089 1.5163082970125543 0.129441414643439 1.0 0.8298258624013215 7 P06730,P42345,Q13418 3 |
| Sphingolipid metabolism in senescence 0.6046682449780671 1.4804104010878587 0.1387637559372878 1.0 0.8313671744999876 13 P42345,Q96G23,Q06136,P16278 4 |
| Insulin signaling in adipocytes normal condition 0.8071013076020788 1.4703708734992191 0.1414613354207528 1.0 0.8313671744999876 3 P42345 1 |
| Insulin signaling in adipocytes diabetic condition 0.8071013076020788 1.4703708734992191 0.1414613354207528 1.0 0.8313671744999876 3 P42345 1 |
| Familial partial lipodystrophy fpld 0.643534977648291 1.453481671164068 0.1460900650533205 1.0 0.8313671744999876 7 O60725 1 |
| Mitochondrial long chain fatty acid betaoxidation 0.5992538123740021 1.4518233808182297 0.1465507210403602 1.0 0.8313671744999876 13 P49748,P23786,O43772 3 |
| Caloric restriction and aging 0.7304491145105982 1.4414080924606485 0.1494694253918393 1.0 0.8323664331453807 4 P43490 1 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.7266322185934104 1.4256700184843338 0.153963614685078 1.0 0.841945172196778 4 P42574,Q07812 2 |
| Mecp2 and associated rett syndrome 0.4911721372593611 1.4153930127075858 0.1569532971543048 1.0 0.8430121824173141 23 P31943,Q03518,P42345,P67809,P52597,P62753 6 |
| Il10 antiinflammatory signaling pathway 0.7224617483716911 1.4084641257415833 0.1589936824936697 1.0 0.8430121824173141 4 P09601 1 |
| Cytosine methylation 0.6946034255913487 1.4011300926683103 0.1611751742817464 1.0 0.8430121824173141 5 P48735,O75874 2 |
| Energy metabolism 0.6027019675467433 1.3875658885229594 0.1652692746419446 1.0 0.8430121824173141 11 Q13555 1 |
| Vitamin d metabolism 0.7796759118605254 1.362236485588056 0.1731232647962133 1.0 0.8568728083025517 3 P38435 1 |
| Type i interferon induction and signaling during sarscov2 infection 0.7767592769905227 1.3507280511955806 0.1767825630783304 1.0 0.8568728083025517 3 P42224 1 |
| Cell cycle 0.3912202449669325 1.346913212766807 0.1780081856146345 1.0 0.8568728083025517 53 Q14674,Q9UBD5,O95067,P14635,Q13535,Q9Y619,Q13042,Q13315,P78527,Q14566,O43683 11 |
| Ccl18 signaling pathway 0.5927196376486763 1.3368423639618532 0.1812740975330606 1.0 0.8568728083025517 11 P00403,P08670,P11166,Q86UE4 4 |
| Progeriaassociated lipodystrophy 0.5852944650970355 1.264763078208825 0.205956270499116 1.0 0.8568728083025517 10 P46063,O60725,O75844 3 |
| Fatty acid betaoxidation 0.5110026127827473 1.2606487285053831 0.2074354340479773 1.0 0.8568728083025517 19 P49748,P23786,O43772,Q16836 4 |
| Autophagy 0.5707160719165543 1.1919264715075748 0.2332900774880923 1.0 0.8850442314704505 10 P42345,P54646 2 |
| Head and neck squamous cell carcinoma 0.540098060395671 1.176810015434228 0.2392713441996563 1.0 0.8949822026641518 14 P06730,P42345,P62753,P54646 4 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5235255239385727 1.173300879279426 0.2406751698089415 1.0 0.8949822026641518 16 P49354,P48729,P50402,O75844,O60725,P55209 6 |
| Endothelin pathways 0.5658118450338979 1.1674091517406715 0.2430451770392525 1.0 0.8949822026641518 10 P16615,P42892,P00403 3 |
| Eicosanoid metabolism via cyclooxygenases cox 0.5816953917986141 1.1631805575585223 0.2447562531173792 1.0 0.8949822026641518 7 Q14914,Q15067 2 |
| Eicosanoid metabolism via lipooxygenases lox 0.5732477597409833 1.1234272668761127 0.2612560747683505 1.0 0.9019317360356214 7 O15254,Q14914,Q15067 3 |
| Hostpathogen interaction of human coronaviruses autophagy 0.6251106411840412 1.1056186753866544 0.2688916030580597 1.0 0.9019317360356214 5 P42345 1 |
| Target of rapamycin tor signaling 0.5534267013886686 1.105495257737919 0.2689450481424176 1.0 0.9019317360356214 10 P54646 1 |
| Glycerophospholipid biosynthetic pathway 0.6397599329035902 1.0667907557141476 0.2860663338944684 1.0 0.914618859549048 4 O15228 1 |
| Proteasome degradation 0.3804441397329095 0.9835579308963962 0.325332918414728 1.0 0.9550617965210132 42 P28074,P28070,P20618,Q99436,P60900,P28072,P49721,P61289 8 |
| Thermogenesis 0.3971238445139379 0.9803290635114812 0.3269237128509514 1.0 0.9550617965210132 27 O43772,Q92922,P42345,P23786,P54646 5 |
| Pilocytic astrocytoma 0.6176512877942981 0.9761411653101674 0.3289945141468446 1.0 0.9550617965210132 4 P62993 1 |
| Preimplantation embryo 0.5412516479947768 0.9732747536451034 0.3304167665064461 1.0 0.9550617965210132 7 Q9P0M6,Q99729 2 |
| Lung fibrosis 0.536594738629198 0.9333543425422732 0.3506370457888428 1.0 0.9772101471106076 6 P09601 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.5064913980244279 0.9260357037881672 0.3544274257764552 1.0 0.9772101471106076 12 P13674,O75718,Q32P28 3 |
| Network map of sarscov2 signaling pathway 0.3884636985250883 0.9253407141442822 0.354788706852339 1.0 0.9772101471106076 30 Q96J02,P06730,P42574,O95067,P14635,P42345,Q9H269,P42224,P31350,Q7Z434,P62753 11 |
| Atm signaling in development and disease 0.3887147370816731 0.9115635063589392 0.3619985405650827 1.0 0.9775903684269313 26 Q13535,P42345,Q13315,P78527,Q14739 5 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.5085926050161389 0.8824217863550701 0.3775487584941066 1.0 0.9775903684269313 10 P54646 1 |
| Aryl hydrocarbon receptor pathway wp2873 0.5716223419394811 0.8800575971340499 0.3788281083671858 1.0 0.9775903684269313 5 O00170,Q15185,Q07812 3 |
| Vitamin a and carotenoid metabolism 0.5689713119315278 0.8690117141823901 0.3848407235633435 1.0 0.9775903684269313 5 Q6NUM9,O94788 2 |
| Nipbl role in dna damage cornelia de lange syndrome 0.5218869223369744 0.8664017782238348 0.3862698691339239 1.0 0.9775903684269313 6 Q13535 1 |
| Striated muscle contraction pathway 0.5179947226479253 0.865079366415777 0.3869952288816547 1.0 0.9775903684269313 7 P08670,P09493 2 |
| Nitric oxide metabolism in cystic fibrosis 0.5852305896088686 0.8448388421039694 0.398200824569547 1.0 0.9879968746102016 4 O14744,Q86X55,Q99873 3 |
| Mirna biogenesis 0.6459675278812582 0.8411130480688238 0.4002846060256673 1.0 0.9879968746102016 3 Q9HAV4 1 |
| Interactions between loxl4 and oxidative stress pathway 0.6425444995622948 0.828197540566255 0.4075586364569665 1.0 0.9895523693175148 3 Q96EB6,Q9BQ95 2 |
| Ferroptosis 0.4060840923410714 0.8202001578057659 0.4121020120316703 1.0 0.9903897452900742 23 P09601,Q9NZ45,Q9NZZ3,P45880,Q15043,P37268 6 |
| Burn wound healing 0.4979616579496736 0.8085032188457165 0.4188009538156914 1.0 0.9903897452900742 9 P08670,P07737 2 |
| Nuclear receptors metapathway 0.3445993565654576 0.8031367998164123 0.4218956697553495 1.0 0.9903897452900742 50 O15217,Q14914,P23786,P08183,Q15067 5 |
| Nocgmppkg mediated neuroprotection 0.4938263660985517 0.788739773292666 0.4302641165412497 1.0 0.9956098288304378 9 Q13555 1 |
| Joubert syndrome 0.381789706968381 0.7812479449467302 0.4346566798024152 1.0 0.9956098288304378 25 P61586,O95613,P41208,P42345,Q13315,Q10713,Q15154,Q13432 8 |
| Dna repair pathways full network 0.3259507218838534 0.7685180255623643 0.4421794858192496 1.0 1.0 56 Q07864,O15360,P27695,P41208,Q13535,Q13315,Q9UQ84,P78527,Q8TAF3 9 |
| Adipogenesis 0.4496113845324509 0.7512281098654267 0.452515385776187 1.0 1.0 16 P43490,O75844 2 |
| Vitamin d receptor pathway 0.463166016049468 0.7298569470792848 0.4654776309546795 1.0 1.0 13 P08183 1 |
| Exrna mechanism of action and biogenesis 0.8138856476079358 0.7184282845385963 0.4724932520849778 1.0 1.0 2 Q9HAV4 1 |
| Atr signaling 0.531595511626568 0.715574586326477 0.474254070526692 1.0 1.0 5 Q13535 1 |
| Cholesterol biosynthesis pathway 0.4603754847429039 0.7154074320830085 0.4743573214272993 1.0 1.0 13 P48449,P37268 2 |
| Nrf2 pathway 0.4076003917256802 0.7150923212016408 0.4745519984776432 1.0 1.0 21 O15217,P09601,Q14914 3 |
| Sars coronavirus and innate immunity 0.806592765460905 0.6943971135634661 0.4874332033868207 1.0 1.0 2 P42224 1 |
| Chromosomal and microsatellite instability in colorectal cancer 0.4330021227351814 0.693615551093157 0.4879233386119037 1.0 1.0 17 P61586,P42574,Q04864,P48729 4 |
| Hippo signaling regulation pathways 0.4231533819938281 0.6748701568086245 0.4997582624005967 1.0 1.0 18 P61586,P54646 2 |
| Microglia pathogen phagocytosis pathway 0.5205839416058419 0.6714124226650084 0.5019578332650059 1.0 1.0 5 O00459,O15143,O00443,P63000 4 |
| Erk pathway in huntingtons disease 0.5197375554505089 0.668042124610765 0.5041067035596103 1.0 1.0 5 P42574,P42858 2 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.4543173000874126 0.6598324125231191 0.5093613808006636 1.0 1.0 12 Q9NR77,Q15907,P20337 3 |
| Interferon type i signaling pathways 0.4268601863263348 0.658578526304385 0.5101664559830086 1.0 1.0 17 P06730,P42345,Q04864,P62753 4 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.4598206547330816 0.6458550191741276 0.5183732524612434 1.0 1.0 10 Q86UE4 1 |
| Hematopoietic stem cell gene regulation by gabp alphabeta complex 0.4707147662908706 0.6392345212225659 0.5226703777885795 1.0 1.0 6 Q13315,P26358 2 |
| G1 to s cell cycle control 0.3778489860782653 0.625335113995618 0.5317511384662386 1.0 1.0 23 Q07864,Q9UBD5,P14635,Q9Y619,Q13315,Q14566 6 |
| Oxidative phosphorylation 0.348929797731393 0.6114040694703703 0.5409321092223129 1.0 1.0 30 P03886,Q86Y39,O75964 3 |
| Mirna regulation of p53 pathway in prostate cancer 0.5040750655212344 0.6063688066241127 0.5442698773687962 1.0 1.0 5 Q13315 1 |
| Cytoplasmic ribosomal proteins 0.3173927486275201 0.587761521141834 0.5566923750213237 1.0 1.0 74 Q07020,P27635,P46778,P62917,P62424,Q02543,P83731,P47914,P46776,P42766,P62266,P25398,P15880,P62753,P50914,P39023,Q9Y3U8,P62910,P62841,P84098,P46782,P36578,P62847,P62750,P61313 25 |
| Circadian rhythm genes 0.3327180042307405 0.5867907627767153 0.5573442413828413 1.0 1.0 44 P62136,Q00839,Q8WXF1,Q9BWF3,P43490,Q15233,Q14103,P04818,Q9Y5V3,P23246,P78527,P54646 12 |
| Neuroinflammation 0.5186347433398435 0.5866216024318929 0.5574578709362004 1.0 1.0 4 P00403 1 |
| Integrated cancer pathway 0.3868572777804939 0.5824306333147201 0.5602766526476726 1.0 1.0 21 P42574,Q13315,P42224,Q13535 4 |
| Pi3kaktmtor vitd3 signaling 0.4966210080143304 0.577524395923692 0.5635852632894791 1.0 1.0 5 P54646 1 |
| Serotonin and anxiety 0.7663360560093331 0.5665027690309153 0.5710520511132122 1.0 1.0 2 P05771 1 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.4474849328287458 0.5600654887851964 0.5754347691683841 1.0 1.0 8 P42345 1 |
| Dna damage response 0.3420276996769928 0.5533685197395333 0.5800110905755544 1.0 1.0 27 P42574,O95067,P14635,Q00535,Q13535,Q13315,Q9Y3B8,Q9BXW9,P35251,P78527,P38398 11 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3406544472722402 0.5498486889505879 0.5824231602840424 1.0 1.0 31 Q16850,P54646,P48449,P37268 4 |
| Mirna regulation of dna damage response 0.3392084837924601 0.5327733585699311 0.5941904779605678 1.0 1.0 28 P42574,O95067,P14635,Q00535,Q13535,Q13315,Q9Y3B8,Q9BXW9,P35251,P78527,P38398 11 |
| Copper homeostasis 0.4847490103537991 0.5323496970133944 0.5944838180563463 1.0 1.0 5 P05067 1 |
| 3q29 copy number variation syndrome 0.4208199021270487 0.5158308753375709 0.6059725362249375 1.0 1.0 13 O94888 1 |
| Pyrimidine metabolism and related diseases 0.4376511663111511 0.5078697889602556 0.6115446628855097 1.0 1.0 7 P27708,P04818,P31350 3 |
| Overview of nanoparticle effects 0.7462077012835264 0.5060803400806758 0.6128002513694 1.0 1.0 2 P09601 1 |
| Somatroph axis gh and its relationship to dietary restriction and aging 0.7429988331388369 0.4966952183964072 0.6194039948557308 1.0 1.0 2 P42345 1 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3906417861694152 0.4881799181170861 0.6254224075810153 1.0 1.0 18 P62993,P61586,Q14739,O94901 4 |
| Inclusion body myositis 0.5438934645876027 0.4794160728998563 0.6316426613596269 1.0 1.0 3 P05067 1 |
| Proximal tubule transport 0.4249021775694799 0.4729990720027756 0.6362138412497624 1.0 1.0 9 P08183 1 |
| Sarscov2 replication organelle formation 0.729871645274204 0.4590609309523292 0.6461904115345158 1.0 1.0 2 Q14457 1 |
| Rett syndrome causing genes 0.389021641016965 0.4493372282600945 0.6531884059776356 1.0 1.0 17 P27695,P28370,P49770,Q9UPW6,P42858,Q9HCS7,Q9Y4A5 7 |
| Mitochondrial complex iii assembly 0.4089744906170473 0.4153126144301113 0.6779130679811103 1.0 1.0 10 O14949,P22695,P47985,Q6DKK2 4 |
| Physiological and pathological hypertrophy of the heart 0.4138482595808687 0.411019169163991 0.6810584787328064 1.0 1.0 7 P61586 1 |
| Pdgf pathway 0.3901667086141067 0.4067299925555397 0.684206309528345 1.0 1.0 15 P00403,P61586,P42224 3 |
| Ppar signaling pathway 0.3697494326428825 0.4034116330447498 0.6866454302629397 1.0 1.0 19 O95864,O15254,O14975,P23786,Q15067 5 |
| G13 signaling pathway 0.368933981621332 0.3988732116681184 0.6899866286558836 1.0 1.0 19 P61586,Q7L576 2 |
| Breast cancer pathway 0.3197988262710883 0.3900586060721906 0.6964932108486228 1.0 1.0 26 P42345,Q13315,Q13535 3 |
| Development of ureteric collection system 0.4449635036496397 0.3893103462499664 0.6970465836432127 1.0 1.0 5 P35222,Q13418,O94813,Q12948 4 |
| Dna irdouble strand breaks and cellular response via atm 0.3197270999592559 0.3881414852434995 0.6979113330269184 1.0 1.0 29 P42574,Q13535,Q13315,Q9UQ84,P78527 5 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.3961639424888292 0.3836718575391132 0.701221673602286 1.0 1.0 12 Q13555,P42224 2 |
| Regulation of actin cytoskeleton 0.3122801452757323 0.3800750163600109 0.7038897307193397 1.0 1.0 41 Q9UQB8,P61586 2 |
| Extracellular vesiclemediated signaling in recipient cells 0.4335952701075701 0.3512795289335745 0.7253786511362266 1.0 1.0 5 P42345 1 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.3880118630493043 0.3478990759628213 0.7279159792527432 1.0 1.0 12 P42345,P62753 2 |
| Wnt signaling pathway 0.3806675515584401 0.3285323574198429 0.7425091830283042 1.0 1.0 13 P61586,P42345 2 |
| Spinal cord injury 0.3504132769753625 0.3270028638558385 0.7436657191475946 1.0 1.0 20 P08670,P61586,P27695 3 |
| Biomarkers for pyrimidine metabolism disorders 0.3884109234340132 0.3146862201967809 0.7529999077927789 1.0 1.0 7 P31350,P04818 2 |
| Triacylglyceride synthesis 0.4218554130003399 0.3135611640658275 0.7538543594788858 1.0 1.0 5 O15228,O00116,Q9NUQ2 3 |
| Lncrna in canonical wnt signaling and colorectal cancer 0.3770887048624606 0.3128859628657894 0.754367302541757 1.0 1.0 13 Q9P0M6,Q00839,P67870,Q9HCK8,P48729,P61978 6 |
| Corticotropinreleasing hormone signaling pathway 0.3133797476643475 0.2940726963364492 0.7687023540696656 1.0 1.0 25 P42892,P54646 2 |
| Dna replication 0.3046168198563163 0.282073376977254 0.7778872467723041 1.0 1.0 27 P40937,Q07864,Q9UBD5,Q9Y619,P49736,P28340,Q14566,P35251 8 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.3729996321247991 0.2761061357318323 0.7824665481591198 1.0 1.0 11 Q7Z434,P42224,P35613 3 |
| Sarscov2 and covid19 pathway 0.4240251060520759 0.2744516416036267 0.7837375616519375 1.0 1.0 4 P35610 1 |
| Interactome of polycomb repressive complex 2 prc2 0.3764987157007631 0.2721670749074532 0.7854935569545456 1.0 1.0 6 Q15022 1 |
| Dna irdamage and cellular response via atr 0.2995695925994389 0.2718712363953203 0.7857210285036724 1.0 1.0 40 O15360,Q13535,P46063,Q13315,Q9UQ84,Q92547,P78527 7 |
| Kallmann syndrome 0.4080713955440703 0.2714669595550225 0.7860319083474767 1.0 1.0 5 Q9P2D1 1 |
| Type 2 papillary renal cell carcinoma 0.3704583676372081 0.2558633349923991 0.7980563668501344 1.0 1.0 9 Q92733 1 |
| Robo4 and vegf signaling pathways crosstalk 0.6394399066511147 0.2391438363364551 0.8109940512415159 1.0 1.0 2 O94813 1 |
| Apoptosis modulation and signaling 0.3410295690112417 0.2287413556943476 0.819069949619653 1.0 1.0 18 O95831,Q9NR28 2 |
| Alzheimers disease 0.2983341042987951 0.2231114929737684 0.8234487336964778 1.0 1.0 90 P16615,P21796,P28070,P28074,P42574,P12235,Q00535,P20618,P42345,P45880,P05067,P60900,P48729,Q99436,P28072,Q14457,P49721 17 |
| Nanoparticle triggered regulated necrosis 0.6298133022170438 0.2203620671515397 0.8255891853204647 1.0 1.0 2 Q13546 1 |
| Dna damage response only atm dependent 0.3345302446553488 0.2178725958315684 0.8275283795974855 1.0 1.0 19 P61586,Q13315,Q16537 3 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.3512338438250812 0.2063135733912532 0.836545976574786 1.0 1.0 13 O00303,P55010 2 |
| Pdgfrbeta pathway 0.353894738306176 0.2005631235230643 0.8410401952656985 1.0 1.0 10 P04049,P62993,P42224 3 |
| Oncostatin m signaling pathway 0.3307283243673344 0.1993493931272033 0.8419894443206819 1.0 1.0 19 P42574,P42345,P42224,P04049,P62993,P62753 6 |
| Ethanol metabolism production of ros by cyp2e1 0.6131855309218293 0.1902093801114923 0.849145061039295 1.0 1.0 2 P36507 1 |
| Alpha 6 beta 4 signaling pathway 0.3458251782990681 0.1856099183593255 0.852750675002865 1.0 1.0 13 P61586,P42345 2 |
| Liver x receptor pathway 0.6102683780630179 0.1852210886695879 0.8530556289032685 1.0 1.0 2 O00767 1 |
| Alzheimers disease and mirna effects 0.2947672174730375 0.1705961053287888 0.8645413605304781 1.0 1.0 92 P21796,P28074,Q00535,P42345,P49721,P16615,P42574,P49720,P05067,P60900,Q14457,Q96IX5,P28070,P48729,P12235,P20618,P45880,Q99436,P28072 19 |
| Nucleotide metabolism 0.3393886155778187 0.1540182777887611 0.8775953239505492 1.0 1.0 11 P28340,P00374,P31350 3 |
| Osteoblast differentiation and related diseases 0.3358947522084263 0.1450286219351349 0.8846882736533903 1.0 1.0 12 P78527 1 |
| Leptin signaling pathway 0.2843761543884365 0.1428477481091207 0.8864104261963437 1.0 1.0 34 P06730,P61586,P42345,Q04864,P42224,P54646,P62753 7 |
| P38 mapk signaling pathway 0.334011442005579 0.1366845999247006 0.891280102754783 1.0 1.0 9 P62993,P42224 2 |
| Serine metabolism 0.3299944905563609 0.1354833662645302 0.892229714793564 1.0 1.0 6 P00374,P04818 2 |
| 16p112 distal deletion syndrome 0.323319908317719 0.1098614881023268 0.9125192256501782 1.0 1.0 8 P62993,Q9H2V7,Q99873 3 |
| Urea cycle and metabolism of amino groups 0.3228823471348325 0.1033298698258405 0.9177011698032812 1.0 1.0 10 Q14353,P54886,P78540,Q03154 4 |
| Gastric cancer network 2 0.312765495663445 0.1030211632416583 0.9179461744826536 1.0 1.0 18 Q14739,Q658Y4,Q86UE4 3 |
| Pathways affected in adenoid cystic carcinoma 0.3019308427423769 0.1024567818234414 0.9183941153729231 1.0 1.0 21 Q13315,P10412 2 |
| Hair follicle development cytodifferentiation part 3 of 3 0.3458844133099892 0.1005188327813468 0.9199324321611606 1.0 1.0 4 Q04721,Q9BZE4,P35222 3 |
| Follicle stimulating hormone fsh signaling pathway 0.3145947856030762 0.0881098462528519 0.929789370640386 1.0 1.0 8 P42345 1 |
| Erbb signaling pathway 0.2970490043786244 0.0800180206331399 0.936222923534692 1.0 1.0 21 P42345,Q13555,Q13557 3 |
| Physicochemical features and toxicityassociated pathways 0.3084254045287921 0.0759929585075945 0.9394247002968236 1.0 1.0 17 P61586,P07737,P07197 3 |
| Genes related to primary cilium development based on crispr 0.3053671628976538 0.0735813053859372 0.9413435469494132 1.0 1.0 18 A0AVF1 1 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.3040671263101954 0.0639929325819825 0.9489758542575628 1.0 1.0 8 O43683 1 |
| 7oxoc and 7betahc pathways 0.3052945386107815 0.0573500913875539 0.9542663188252808 1.0 1.0 10 O15118,O14975 2 |
| Hepatitis c and hepatocellular carcinoma 0.305250298047697 0.0540066228536834 0.9569298876703174 1.0 1.0 11 P42574,P31350 2 |
| Embryonic stem cell pluripotency pathways 0.3048872852191709 0.0530866211679597 0.9576628911830732 1.0 1.0 11 P62993,P42345 2 |
| Epo receptor signaling 0.3001885361213615 0.0500928479122919 0.9600483991239268 1.0 1.0 9 P62993,P42224 2 |
| Cancer immunotherapy by ctla4 blockade 0.4789964994165773 0.0485822567854911 0.9612522103003756 1.0 1.0 2 O00459 1 |
| Osx and mirnas in tooth development 0.4763710618436432 0.0473458079877481 0.962237619500676 1.0 1.0 2 Q04721 1 |
| Arachidonate epoxygenase epoxide hydrolase 0.47607934655778 0.047211172560951 0.9623449230365156 1.0 1.0 2 P20674 1 |
| Onecarbon metabolism 0.3025264602501477 0.043592827378156 0.965228969187332 1.0 1.0 14 P00374,P04818,P26358 3 |
| Oxidative damage response 0.2859228971962667 0.0434440752157528 0.9653475439061144 1.0 1.0 6 P42574,P60953,Q12933,O95429,O95551 5 |
| Mapk pathway in congenital thyroid cancer 0.2997664915353252 0.0411734704179961 0.9671576032719232 1.0 1.0 4 P36507,P04049,Q02750 3 |
| Disorders of folate metabolism and transport 0.2897780187900146 0.0350208898839512 0.9720630833705426 1.0 1.0 8 P00374,P04818,P34897 3 |
| Il9 signaling pathway 0.2914182111829678 0.0317110865431526 0.9747024535512876 1.0 1.0 9 P62993,P42224 2 |
| Photodynamic therapyinduced hif1 survival signaling 0.2932360204169493 0.0252181436844579 0.9798809649907114 1.0 1.0 11 P53985 1 |
| Leptininsulin signaling overlap 0.3232205367561207 0.0222852189378707 0.9822204395343064 1.0 1.0 2 O14654 1 |
| Mirna regulation of prostate cancer signaling pathways 0.28584366003356 0.0146807001233619 0.9882869167710244 1.0 1.0 10 P62993,P42345 2 |
| Phosphoinositides metabolism 0.2808936042733239 0.0118825397924414 0.9905193280605308 1.0 1.0 9 Q8TBX8 1 |
| Camkk2 pathway 0.2854674435677603 0.0001109161461916 0.9999115017195914 1.0 1.0 13 P09601 1 |
|
|
